Singapore markets closed

Xencor, Inc. (XNCR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.26-0.57 (-1.64%)
At close: 04:00PM EST
34.25 -0.01 (-0.03%)
After hours: 06:09PM EST
Full screen
Trade prices are not sourced from all markets
Previous close34.83
Open34.75
Bid34.25 x 800
Ask34.38 x 800
Day's range34.26 - 36.02
52-week range30.12 - 58.35
Volume500,529
Avg. volume257,567
Market cap2.004B
Beta (5Y monthly)0.76
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Xencor, inc (XNCR) Q3 2021 Earnings Call Transcript

    With me on the call today are Bassil Dahiyat, President and Chief Executive Officer; Allen Yang, Chief Medical Officer; John Desjarlais, Chief Scientific Officer; and John Kuch, Chief Financial Officer. Before we begin, I would like to remind you that during the course of this conference call, Xencor management may make forward-looking statements, including statements regarding the company's future financial and operating results, future market conditions, the plans and objectives of management, future operations, the company's partnering efforts, capital requirements, future product offerings and research and development programs.

  • Zacks

    Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates

    Xencor (XNCR) delivered earnings and revenue surprises of 8.00% and 11.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Zacks

    Ironwood (IRWD) Q3 Earnings Top, Sales Hurt by Lower Price

    Ironwood (IRWD) witnesses flat year-over-year sales as growth in demand for Linzess gets partially offset by lower net price of the drug. The company maintains revenue guidance. Stock down.